 |
abatacept |
|---|---|
| Trade Name | Orencia |
| Orphan Indication | Type 1 diabetes mellitus patients with residual beta cell function |
| USA Market Approval | USA |
| USA Designation Date | 2013-05-30 00:00:00 |
| Sponsor | Orban Biotech LLC;64 Aspinwall Avenue;Brookline, Massachusetts, 02446 |
